New drug hopes to improve leg blood flow in PAD patients
NCT ID NCT06774040
First seen Nov 01, 2025 · Last updated May 18, 2026 · Updated 28 times
Summary
This study tests a new drug called etrinabdione in 30 adults with peripheral arterial disease (PAD), a condition where leg arteries narrow, causing pain while walking. Participants take the drug twice daily for 12 months to see if it is safe and if it improves blood flow and walking ability. The trial starts with a low dose and moves to a higher dose if the low dose is safe after 3 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERIAL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Universitario Reina Sofía
Córdoba, 14014, Spain
Conditions
Explore the condition pages connected to this study.